Position in OCUL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$6,271,444
+$1,796,828 QoQ
Shares Held
638,640
+20.9% QoQ
Ownership
0.291%
of shares outstanding
% of Portfolio
2.48%
of 13F equity value
Holder Rank
#41
of 257 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 74%
Shared 0%
None 26%
Common Shares in OCUL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Second Line Capital, LLC holds $6,830,265 across 2 Biotechnology names. OCUL ranks #1 (91.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | OCUL |
Ocular Therapeutix, Inc
This page
|
638,640 | $6,271,444 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,125 | $558,821 |
All Filings in OCUL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,271,444 | 638,640 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $4,474,616 | 528,290 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,079,056 | 500,746 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,704,839 | 402,467 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $3,577,133 | 385,467 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $2,536,898 | 346,098 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,904,436 | 340,098 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,286,447 | 262,810 | Shares | Sole | 2024-11-19 | |
| 2024-06-30 | $1,797,620 | 262,810 | Shares | Sole | 2024-08-16 | |
| No filing history on record for this holder in this stock. | ||||||